[
balram bhargava
]
India's Covid-19 vaccines will be effective against new variants, says ICMR
ANI, Thiruvananthapuram
PUBLISHED ON FEB 19, 2021 10:16 AM IST
Dr Balram Bhargava, Director General of ICMR, said a paper on Covaxin's neutralisation potential against the UK strain has been accepted for publication.
‘Bharat Biotech vaccine approved in clinical trial mode, consent of participants has to be taken’: ICMR
By hindustantimes.com | Edited by: Amit Chaturvedi | Hindustan Times, New Delhi
UPDATED ON JAN 06, 2021 10:17 AM IST
Industry experts and some opposition leaders have expressed concern over the absence of Phase 3 trial data on Covaxin.
‘Will take that vaccine...’: Experts explain why Bharat Biotech’s vaccine got approval
By hindustantimes.com | Edited by Poulomi Ghosh | Hindustan Times, New Delhi
UPDATED ON JAN 05, 2021 09:38 PM IST
Government experts on Tuesday clarified why Covaxin has been given the nod for restricted emergency use.
‘2 vaccines a result proactive approach,’ says DG-ICMR
By Rhythma Kaul | Hindustan Times, New Delhi
UPDATED ON JAN 04, 2021 05:48 AM IST
“These kinds of approvals are purely data-driven, and in both these vaccines Phase 2 immunogenicity has been well established. The question of approving a vaccine without adequate data does not arise as the expert panel minutely scans the national as well international data presented to them before granting an approval,” said DG-ICMR.
Bharat Biotech vaccine more likely to work against newer strains like UK variant: Vardhan
By Press Trust of India | Posted by Kanishka Sarkar | New Delhi
UPDATED ON JAN 04, 2021 12:08 AM IST
India’s drugs regulator on Sunday approved Oxford Covid-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country, paving the way for a massive inoculation drive.
‘Bharat Biotech vaccine may have some advantages...’: ICMR chief on Covaxin, mutant strain
By hindustantimes.com | Edited by Poulomi Ghosh | Hindustan Times, New Delhi
UPDATED ON JAN 03, 2021 08:16 PM IST
Covaxin is a whole virion inactivated Covid-19 vaccine while Oxford vaccine works differently — it produces surface spike protein priming the immune system to attack the SARS-CoV-2 virus if it later infects the body.
Experimental therapies not to be used indiscriminately, warns ICMR
By Rhythma Kaul | Hindustan Times, New Delhi
UPDATED ON DEC 30, 2020 01:59 AM IST
The warning comes in the backdrop of the discovery in the UK of a new variant of the virus that causes Covid-19. The new strain, scientists say, is more transmissible than the original one.
Non-judicious use of therapies for Covid-19 leads to virus mutations: ICMR chief
By Asian News International | Posted by Srivatsan K C | New Delhi
PUBLISHED ON DEC 29, 2020 09:03 PM IST
“Those therapies which are being touted as ‘anti-viral’ or ‘anti-COVID therapies’ and they have do not have benefits established in a scientific research paper, those therapies should not be used as they will put tremendous immune pressure on the virus and it will tend to mutate more, Dr Bhargava told ANI.
ICMR chief Balram Bhargava admitted to AIIMS Trauma Centre for Covid-19 treatment
By hindustantimes.com | Edited by Arpan Rai | Hindustan Times, New DElhi
UPDATED ON DEC 18, 2020 10:40 PM IST
Bhargava, who was admitted to the AIIMS Trauma Centre, is recovering well and likely to be discharged soon, the report added.
‘Need to follow Covid-19 protocol even after vaccine is available, masks here to stay’: ICMR chief
By hindustantimes.com | Edited by: Amit Chaturvedi | HIndustan Times, New Delhi
UPDATED ON NOV 29, 2020 09:10 AM IST
Speaking at a webinar hosted by Lucknow’s King George’s Medical University on Saturday, professor Balram Bhargava said that India is making rapid progress as far as the development of Covid-19 vaccine is concerned.
Delhi health minister Satyendar Jain bats for plasma therapy
By Anonna Dutt | Hindustan Times, New Delhi
UPDATED ON OCT 22, 2020 06:41 AM IST
ICMR had conducted a pan-India study to determine the role of plasma therapy, and the Union health ministry had added it as one of the investigational therapies in the national protocol for treating Covid-19 patients.
Plasma therapy may not be used on patients
By Rhythma Kaul | Hindustan Times, New Delhi
UPDATED ON OCT 21, 2020 02:33 AM IST
ICMR had conducted a pan-India study to determine the role of plasma therapy, and the Union health ministry had added it as one of the investigational therapies in the national protocol for treating Covid-19 patients.
30 million frontline workers to get Covid-19 vaccine in phase 1
By Rhythma Kaul | Hindustan Times, New Delhi
UPDATED ON OCT 21, 2020 01:35 AM IST
The 30 million include 7 million doctors and paramedics, in addition to 20 million other frontline health workers, Union health secretary Rajesh Bhushan said on the sidelines of a Covid-19 media briefing on Tuesday.
ICMR DG hails Gandhian perspective of healthy living in Covid-19 times
By Asian News International | Posted by Kanishka Sarkar | New Delhi
UPDATED ON OCT 03, 2020 10:13 AM IST
he ICMR Director-General opined that Gandhi was aware and concerned about individual health and poured his thoughts in the book “Key to Health”.
Covid-19: Key highlights of second sero-survey findings
By hindustantimes.com | Edited by Shivani Kumar | Hindustan Times, New Delhi
UPDATED ON SEP 29, 2020 07:40 PM IST
As per the findings, a considerable population still vulnerable to Covid-19 which has killed over 96,300 people across the country.
Delhi LG asks expert panel to suggest measures to tackle Covid-19 situation: Report
By Press Trust of India | Posted by Kanishka Sarkar | New Delhi
PUBLISHED ON SEP 22, 2020 06:33 PM IST
Delhi recorded 4,071 cases on September 19; 4,127 on September 18; 4,432 on September 17; 4,473 on September 16 and 4,263 on September 15.
India’s Covid-19 recovery rate surges past 78%, one of the highest globally: Govt
By hindustantimes.com| Edited by Kanishka Sarkar | Hindustan Times, New Delhi
UPDATED ON SEP 15, 2020 10:25 PM IST
As of Tuesday, 3,859,399 people had recovered from Covid-19 and the country’s recovery tally exceeded the active cases by 2,869,338.
Covid-19: The daredevils who defy scientific advice
By Payal S Kapoor
UPDATED ON AUG 30, 2020 09:14 PM IST
Many continue to go about their lives, refusing to follow simple preventive health guidelines, as if the world is already in a post-pandemic era
Clinical study of Covid-19 vaccine on human volunteers now in India
By hindustantime.com| Edited by Sabir Hussain | Hindustan Times, New Delhi
UPDATED ON JUL 14, 2020 06:38 PM IST
Two pharmaceutical companies are carrying out clinical studies on approximately 1,000 human volunteers each at different sites.
The intersection of politics and science, writes Chanakya
By Chanakya | Hindustan Times
UPDATED ON JUL 05, 2020 06:03 AM IST
The two most powerful tools in any country’s armoury, when it comes to fighting the Covid-19 pandemic, are data and science, and political leaders through the centuries have had an uncomfortable relationship with both.
WHO approves India’s cost-effective TB test
By HT Correspondent | Hindustan Times, New Delhi
UPDATED ON JAN 17, 2020 12:37 AM IST
The WHO’’s Global TB Programme has included TrueNat TB test, a new molecular test that detects TB as well as resistance to the drug Rifampicin in about 90 minutes, in its rapid communication document on molecular investigative procedure in laboratory medicine and pharmacology.
National Aids Research Institute to drop focus on HIV, undergo name change
By Nozia Sayyed | Pune
UPDATED ON FEB 17, 2019 07:45 AM IST
NARI director Dr Samiran Panda said in an interview that this was among the issues discussed during the February 8 visit by ICMR (Indian Council of Medical Research) director Dr Balram Bhargava to the institute at Bhosari, Pune.